Open Access. Powered by Scholars. Published by Universities.®
- Keyword
-
- Science & Technology (9)
- Life Sciences & Biomedicine (8)
- Urology & Nephrology (5)
- APOL1 RISK VARIANTS (2)
- FOCAL SEGMENTAL GLOMERULOSCLEROSIS (2)
-
- KIDNEY-DISEASE (2)
- ANAPHYLACTOID REACTIONS;; PARENTERAL IRON;; DEXTRAN;; GUIDELINES;; SAFETY;; ANEMIA;; SEVERITY;; PRODUCTS;; UPDATE;; Hematology (1)
- ANCA - associated vasculitis;; Anti-GBM disease;; Gpa;; Necrotizing RPGN;; dual antibody-positive disease (1)
- APOL1 (1)
- APOL1 risk variants;; kidney disease;; podocyte;; necrosis;; lysosomal;; membrane permeability;; HIV-ASSOCIATED NEPHROPATHY;; TRYPANOSOME LYTIC FACTOR;; CHRONIC;; KIDNEY-DISEASE;; LIPID-BINDING PROTEIN;; AUTOPHAGIC CELL-DEATH;; STAGE;; RENAL-DISEASE;; AFRICAN-AMERICANS;; HUMAN SERUM;; TRYPANOLYTIC FACTOR;; APOLIPOPROTEIN-L;; Physiology;; Urology & Nephrology (1)
- APOL1;; Risk variants;; Domain;; Integrity;; Toxicity;; hiv-associated nephropathy;; lipid-binding protein;; autophagic;; cell-death;; apolipoprotein-l gene;; kidney-disease;; african-americans;; l1;; association;; expression;; tissue;; Pathology (1)
- Actin cytoskeleton;; IQ domain GTPase-activating protein 1;; Nephrin;; Podocyte;; focal segmental glomerulosclerosis;; nephropathy;; components;; proteins;; disease;; phosphorylation;; mechanisms;; binding;; models;; Cell Biology (1)
- Acute kidney injury;; alveolar hemorrhage;; starry-sky;; subepithelial deposits (1)
- Adaptive cell transfer (1)
- Administration (1)
- Aflibercept (Eylea) (1)
- Aged;; Cohort Studies;; Disease Progression;; *Electronic Health Records;; Female;; Glomerular Filtration Rate;; Humans;; Longitudinal Studies;; Male;; Middle Aged;; Models (1)
- Albumin infusion;; cirrhosis;; hypervolemic hyponatremia;; hyponatremia;; salt poor albumin (1)
- Anemia;; erythropoiesis-stimulating agent;; ferric pyrophosphate citrate;; hemodialysis;; iron (1)
- Angiotensin II;; angiotensin II type 1 receptor blockade;; glucose;; silencing mediator of retinoic acid and thyroid hormone receptor;; vitamin D receptor;; vitamin-d-receptor;; hiv-associated nephropathy;; nuclear;; hormone-receptors;; co-repressor;; diabetic-nephropathy;; podocytes;; activation;; hdac3;; d-3;; phosphorylation;; Physiology;; Urology & Nephrology (1)
- Antineoplastic Agents/*adverse effects;; Glomerulonephritis/*etiology;; Hematopoietic Stem Cell Transplantation/*adverse effects;; Humans;; Kidney Glomerulus/*drug effects;; Neoplasms/*complications/*therapy;; Paraneoplastic Syndromes/*etiology (1)
- Apol1;; HIV-associated nephropathy;; heroin nephropathy;; opiates;; podocytes (1)
- Apolipoprotein L1;; autophagy;; endocytosis;; cytotoxicity;; RNA splicing;; hiv-associated nephropathy;; chaperone-mediated autophagy;; trypanosome;; lytic factor;; lipid-binding protein;; l gene-cluster;; cell-death;; lysosomal biogenesis;; kidney-disease;; apol1;; variants;; Cell Biology;; Physiology (1)
- Apolipoproteins/genetics/*metabolism;; Cell Line;; Culture Media (1)
- Apoptosis;; hypomagnesemia;; inflammation;; nephrotoxicity;; oxidative;; stress;; ORGANIC CATION TRANSPORTER-2;; INDUCED RENAL INJURY;; INDUCED;; NEPHROTOXICITY;; OXIDATIVE STRESS;; INFLAMMATORY RESPONSE;; TESTICULAR;; CANCER;; GENE-EXPRESSION;; DEFICIENT RATS;; CELL APOPTOSIS;; BLOOD-PRESSURE;; Physiology;; Urology & Nephrology (1)
- Arginine vasopressin;; cell proliferation;; chronic kidney disease;; hypertension;; inflammation;; metabolic syndrome;; osteopenia;; social behavior (1)
- Attitude to Computers;; *Data Display;; *Electronic Health Records;; Humans;; Natural Language Processing;; Software;; Surveys and Questionnaires;; *User-Computer Interface;; electronic health record;; summarization;; visualization (1)
- BEVACIZUMAB (1)
- BLOCKER USE (1)
- BLOOD-PRESSURE (1)
Articles 1 - 30 of 92
Full-Text Articles in Medicine and Health Sciences
Acute Kidney Injury In Patients Hospitalized With Covid-19, J. S. Hirsch, J. H. Ng, D. W. Ross, H. H. Shah, R. L. Barnett, A. D. Hazzan, S. Fishbane, K. D. Jhaveri, M. Abate, A. Bellucci, M. C. Bhaskaran, M. Gitman, C. Halinski, S. Hasan, S. Hong, Y. Khanin, A. Kuan, V. Madireddy, D. Malieckal, A. Muzib
Acute Kidney Injury In Patients Hospitalized With Covid-19, J. S. Hirsch, J. H. Ng, D. W. Ross, H. H. Shah, R. L. Barnett, A. D. Hazzan, S. Fishbane, K. D. Jhaveri, M. Abate, A. Bellucci, M. C. Bhaskaran, M. Gitman, C. Halinski, S. Hasan, S. Hong, Y. Khanin, A. Kuan, V. Madireddy, D. Malieckal, A. Muzib
Journal Articles
© 2020 International Society of Nephrology The rate of acute kidney injury (AKI) associated with patients hospitalized with Covid-19, and associated outcomes are not well understood. This study describes the presentation, risk factors and outcomes of AKI in patients hospitalized with Covid-19. We reviewed the health records for all patients hospitalized with Covid-19 between March 1, and April 5, 2020, at 13 academic and community hospitals in metropolitan New York. Patients younger than 18 years of age, with end stage kidney disease or with a kidney transplant were excluded. AKI was defined according to KDIGO criteria. Of 5,449 patients admitted …
Covid-19 In Kidney Transplant Recipients, V. Nair, N. Jandovitz, J. S. Hirsch, G. Nair, M. Abate, M. Bhaskaran, E. Grodstein, I. Berlinrut, D. Hirschwerk, S. L. Cohen, K. W. Davidson, A. J. Dominello, G. A. Osorio, S. Richardson, L. W. Teperman, E. P. Molmenti
Covid-19 In Kidney Transplant Recipients, V. Nair, N. Jandovitz, J. S. Hirsch, G. Nair, M. Abate, M. Bhaskaran, E. Grodstein, I. Berlinrut, D. Hirschwerk, S. L. Cohen, K. W. Davidson, A. J. Dominello, G. A. Osorio, S. Richardson, L. W. Teperman, E. P. Molmenti
Journal Articles
No abstract provided.
Mir193a Modulation And Podocyte Phenotype, A. Jha, S. Saha, K. Ayasolla, H. Vashistha, A. Malhotra, K. Skorecki, P. C. Singhal
Mir193a Modulation And Podocyte Phenotype, A. Jha, S. Saha, K. Ayasolla, H. Vashistha, A. Malhotra, K. Skorecki, P. C. Singhal
Journal Articles
Apolipoprotein L1 (APOL1)-miR193a axis has been reported to play a role in the maintenance of podocyte homeostasis. In the present study, we analyzed transcription factors relevant to miR193a in human podocytes and their effects on podocytes' molecular phenotype. The motif scan of the miR193a gene provided information about transcription factors, including YY1, WT1, Sox2, and VDR-RXR heterodimer, which could potentially bind to the miR193a promoter region to regulate miR193a expression. All structure models of these transcription factors and the tertiary structures of the miR193a promoter region were generated and refined using computational tools. The DNA-protein complexes of the miR193a promoter …
Inflammation And Erythropoiesis-Stimulating Agent Hyporesponsiveness: A Critical Connection, H. H. Shah, N. N. Uppal, S. Fishbane
Inflammation And Erythropoiesis-Stimulating Agent Hyporesponsiveness: A Critical Connection, H. H. Shah, N. N. Uppal, S. Fishbane
Journal Articles
No abstract provided.
Erythropoiesis-Stimulating Agent Treatment In Patients With Covid-19., S. Fishbane, J. S. Hirsch
Erythropoiesis-Stimulating Agent Treatment In Patients With Covid-19., S. Fishbane, J. S. Hirsch
Journal Articles
No abstract provided.
Covid-19 Therapeutic Options For Patients With Kidney Disease, H. Izzedine, K. D. Jhaveri, M. A. Perazella
Covid-19 Therapeutic Options For Patients With Kidney Disease, H. Izzedine, K. D. Jhaveri, M. A. Perazella
Journal Articles
No abstract provided.
Novel Approaches To Arteriovenous Access Creation, Maturation, Suitability, And Durability For Dialysis, M. V. Devita, S. K. Khine, H. Shivarov
Novel Approaches To Arteriovenous Access Creation, Maturation, Suitability, And Durability For Dialysis, M. V. Devita, S. K. Khine, H. Shivarov
Journal Articles
© 2020 Since the arteriovenous fistula (AVF) was first conceived over 50 years ago, the goal to create a vascular conduit with predictable and reproducible maturation and durability continues to elude caregivers. Recently, however, advances in the understanding of vascular biology and new technologies now provides us with some optimism; we are moving toward a viable solution. A quickly maturing, sustainable, and durable arteriovenous access may soon be attainable. This review will discuss these advances. There are novel approaches to AVF creation and devices to enhance maturation, advances in arteriovenous graft material(s), and devices to safely prolong the use of …
Randomized Controlled Trial Of Difelikefalin For Chronic Pruritus In Hemodialysis Patients, S. Fishbane, V. Mathur, M. J. Germain, S. Shirazian, S. Bhaduri, C. Munera, R. H. Spencer, F. Menzaghi
Randomized Controlled Trial Of Difelikefalin For Chronic Pruritus In Hemodialysis Patients, S. Fishbane, V. Mathur, M. J. Germain, S. Shirazian, S. Bhaduri, C. Munera, R. H. Spencer, F. Menzaghi
Journal Articles
No abstract provided.
Thrombotic Microangiopathy In A Patient With Covid-19., Kd Jhaveri, Lr Meir, Bs Flores Chang, R Parikh, R Wanchoo, Ml Barilla-Labarca, V Bijol, N Hajizadeh
Thrombotic Microangiopathy In A Patient With Covid-19., Kd Jhaveri, Lr Meir, Bs Flores Chang, R Parikh, R Wanchoo, Ml Barilla-Labarca, V Bijol, N Hajizadeh
Journal Articles
No abstract provided.
Clinically Significant Anticardiolipin Antibodies Associated With Covid-19, S Hossri, M Shadi, Z Hamarsha, R Schneider, D El-Sayegh
Clinically Significant Anticardiolipin Antibodies Associated With Covid-19, S Hossri, M Shadi, Z Hamarsha, R Schneider, D El-Sayegh
Journal Articles
No abstract provided.
Acute Kidney Injury In Patients With Covid-19: An Update On The Pathophysiology., H. Izzedine, K. D. Jhaveri
Acute Kidney Injury In Patients With Covid-19: An Update On The Pathophysiology., H. Izzedine, K. D. Jhaveri
Journal Articles
No abstract provided.
Covid-19 And Solid Organ Transplant Outcomes, V. Nair, N. Jandovitz, K. D. Jhaveri, E. Molmenti
Covid-19 And Solid Organ Transplant Outcomes, V. Nair, N. Jandovitz, K. D. Jhaveri, E. Molmenti
Journal Articles
No abstract provided.
Covid-19 In Hospitalized Patients On Chronic Peritoneal Dialysis: A Case Series, M. Sachdeva, N. N. Uppal, J. S. Hirsch, J. H. Ng, D. Malieckal, S. Fishbane, K. D. Jhaveri
Covid-19 In Hospitalized Patients On Chronic Peritoneal Dialysis: A Case Series, M. Sachdeva, N. N. Uppal, J. S. Hirsch, J. H. Ng, D. Malieckal, S. Fishbane, K. D. Jhaveri
Journal Articles
No abstract provided.
De Novo Anca-Associated Vasculitis With Glomerulonephritis In Covid-19., N. N. Uppal, N. Kello, H. H. Shah, Y. Khanin, I. R. De Oleo, E. Epstein, P. Sharma, C. P. Larsen, V. Bijol, K. D. Jhaveri
De Novo Anca-Associated Vasculitis With Glomerulonephritis In Covid-19., N. N. Uppal, N. Kello, H. H. Shah, Y. Khanin, I. R. De Oleo, E. Epstein, P. Sharma, C. P. Larsen, V. Bijol, K. D. Jhaveri
Journal Articles
No abstract provided.
Outcomes Of Patients With End-Stage Kidney Disease Hospitalized With Covid-19., J. H. Ng, J. S. Hirsch, R. Wanchoo, M. Sachdeva, V. Sakhiya, S. Hong, K. D. Jhaveri, S. Fishbane, Northwell Covid-19 Research Consortium, Northwell Nephrology Covid-19 Research Consortium
Outcomes Of Patients With End-Stage Kidney Disease Hospitalized With Covid-19., J. H. Ng, J. S. Hirsch, R. Wanchoo, M. Sachdeva, V. Sakhiya, S. Hong, K. D. Jhaveri, S. Fishbane, Northwell Covid-19 Research Consortium, Northwell Nephrology Covid-19 Research Consortium
Journal Articles
Given the high risk of infection-related mortality, patients with end-stage kidney disease (ESKD) may be at increased risk with COVID-19. To assess this, we compared outcomes of patients with and without ESKD, hospitalized with COVID-19. This was a retrospective study of patients admitted with COVID-19 from 13 New York. hospitals from March 1, 2020, to April 27, 2020, and followed through May 27, 2020. We measured primary outcome (in-hospital death), and secondary outcomes (mechanical ventilation and length of stay), Of 10,482 patients with COVID-19, 419 had ESKD. Patients with ESKD were older, had a greater percentage self-identified as Black, and …
Response To Thrombotic Microangiopathy: Covid-19 Or Hydroxychloroquine?, R. Wanchoo, M. L. Barilla-Labarca, K. D. Jhaveri
Response To Thrombotic Microangiopathy: Covid-19 Or Hydroxychloroquine?, R. Wanchoo, M. L. Barilla-Labarca, K. D. Jhaveri
Journal Articles
No abstract provided.
Renal Infarction In Covid-19 Patient, A. Ammous, M. A. Ghaffar, E. El-Charabaty, S. El-Sayegh
Renal Infarction In Covid-19 Patient, A. Ammous, M. A. Ghaffar, E. El-Charabaty, S. El-Sayegh
Journal Articles
No abstract provided.
Home Dialysis In The Time Of Covid-19: Reflections On Rapidly Changing Policies., M. Sachdeva, K. D. Jhaveri, S. Fishbane
Home Dialysis In The Time Of Covid-19: Reflections On Rapidly Changing Policies., M. Sachdeva, K. D. Jhaveri, S. Fishbane
Journal Articles
No abstract provided.
Pathophysiology And Pathology Of Acute Kidney Injury In Patients With Covid-19, J. H. Ng, V. Bijol, M. A. Sparks, M. E. Sise, H. Izzedine, K. D. Jhaveri
Pathophysiology And Pathology Of Acute Kidney Injury In Patients With Covid-19, J. H. Ng, V. Bijol, M. A. Sparks, M. E. Sise, H. Izzedine, K. D. Jhaveri
Journal Articles
© 2020 National Kidney Foundation, Inc. Acute kidney injury (AKI) is common among hospitalized patients with Coronavirus Infectious Disease 2019 (COVID-19), with the occurrence of AKI ranging from 0.5% to 80%. The variability in the occurrence of AKI has been attributed to the difference in geographic locations, race/ethnicity, and severity of illness. AKI among hospitalized patients is associated with increased length of stay and in-hospital deaths. Even patients with AKI who survive to hospital discharge are at risk of developing chronic kidney disease or end-stage kidney disease. An improved knowledge of the pathophysiology of AKI in COVID-19 is crucial to …
Alterations In Plasma Membrane Ion Channel Structures Stimulate Nlrp3 Inflammasome Activation In Apol1 Risk Milieu, A. Jha, V. Kumar, S. Haque, K. Ayasolla, S. Saha, X. Lan, A. Malhotra, M. A. Saleem, K. Skorecki, P. C. Singhal
Alterations In Plasma Membrane Ion Channel Structures Stimulate Nlrp3 Inflammasome Activation In Apol1 Risk Milieu, A. Jha, V. Kumar, S. Haque, K. Ayasolla, S. Saha, X. Lan, A. Malhotra, M. A. Saleem, K. Skorecki, P. C. Singhal
Journal Articles
© 2019 Federation of European Biochemical Societies We evaluated alterations in the structural configurations of channels and activation of nucleotide-binding domain, leucine-rich-containing family, pyrin domain-containing-3 (NLRP3) inflammasome formation in apolipoprotein L1 (APOL1) risk and nonrisk milieus. APOL1G1- and APOL1G2-expressing podocytes (PD) displayed enhanced K+ efflux, induction of pyroptosis, and escalated transcription of interleukin (IL)-1β and IL-18. APOL1G1- and APOL1G2-expressing PD promoted the transcription as well as translation of proteins involved in the formation of inflammasomes. Since glyburide (a specific inhibitor of K+ efflux channels) inhibited the transcription of NLRP3, IL-1β, and IL-18, the role of K+ efflux in the activation …
The Relationship Between Medication Discrepancies And Hospitalization Risk Among Patients With Advanced Ckd, V. Sakhiya, J. James, K. D. Jhaveri, M. Zhang, J. H. Ng, C. Halinski Np, J. Tomanguillo-Chumbe, S. Fishbane
The Relationship Between Medication Discrepancies And Hospitalization Risk Among Patients With Advanced Ckd, V. Sakhiya, J. James, K. D. Jhaveri, M. Zhang, J. H. Ng, C. Halinski Np, J. Tomanguillo-Chumbe, S. Fishbane
Journal Articles
No abstract provided.
'Whatsapp (R)' Ening In Nephrology Training, K. D. Jhaveri, B. Pascarelli, A. Hasan, A. Kozikowski, S. Fishbane, R. Pekmezaris
'Whatsapp (R)' Ening In Nephrology Training, K. D. Jhaveri, B. Pascarelli, A. Hasan, A. Kozikowski, S. Fishbane, R. Pekmezaris
Journal Articles
No abstract provided.
Treatment Of Parvovirus B19 Viremia To Facilitate Kidney Transplantation In A Patient With Collapsing Glomerulopathy., V. Nair, N. Jandovitz, K. D. Jhaveri, D. Hirschwerk, E. Grodstein, V. Bijol, E. Molmenti, L. Teperman
Treatment Of Parvovirus B19 Viremia To Facilitate Kidney Transplantation In A Patient With Collapsing Glomerulopathy., V. Nair, N. Jandovitz, K. D. Jhaveri, D. Hirschwerk, E. Grodstein, V. Bijol, E. Molmenti, L. Teperman
Journal Articles
Collapsing glomerulopathy (CG) is a severe form of glomerulopathy which results in nephrotic syndrome and often ensues in rapid progression to end-stage kidney disease (ESKD). Although most commonly a result of HIV infection, other conditions such as parvovirus B19 (PB19) infection have been associated with CG. We present a case of an 18-year-old male with CG associated with PB19 infection who was heterozygous for APOL1 G1 and G2 genetic variants. In an attempt to treat, he was started on intravenous immunoglobulin (IVIg), however rapidly progressed to ESKD. During workup for a living donor kidney transplant he was found to have …
Thrombotic Microangiopathy And Acute Kidney Injury Induced After Intravitreal Injection Of Vascular Endothelial Growth Factor Inhibitors Vegf Blockade-Related Tma After Intravitreal Use, R. M. Hanna, N. Tran, S. S. Patel, J. Hou, K. D. Jhaveri, R. Parikh, U. Selamet, L. Ghobry, V. Bijol, I. B. Kurtz, +6 Additional Authors
Thrombotic Microangiopathy And Acute Kidney Injury Induced After Intravitreal Injection Of Vascular Endothelial Growth Factor Inhibitors Vegf Blockade-Related Tma After Intravitreal Use, R. M. Hanna, N. Tran, S. S. Patel, J. Hou, K. D. Jhaveri, R. Parikh, U. Selamet, L. Ghobry, V. Bijol, I. B. Kurtz, +6 Additional Authors
Journal Articles
No abstract provided.
Clinical Management Of Hyperkalemia, B. F. Palmer, J. J. Carrero, D. J. Clegg, G. B. Colbert, M. Emmett, S. Fishbane, D. J. Hain, E. Lerma, M. Onuigbo, M. R. Weir, +3 Additional Authors
Clinical Management Of Hyperkalemia, B. F. Palmer, J. J. Carrero, D. J. Clegg, G. B. Colbert, M. Emmett, S. Fishbane, D. J. Hain, E. Lerma, M. Onuigbo, M. R. Weir, +3 Additional Authors
Journal Articles
© 2020 Mayo Foundation for Medical Education and Research Hyperkalemia is an electrolyte abnormality with potentially life-threatening consequences. Despite various guidelines, no universally accepted consensus exists on best practices for hyperkalemia monitoring, with variations in precise potassium (K+) concentration thresholds or for the management of acute or chronic hyperkalemia. Based on the available evidence, this review identifies several critical issues and unmet needs with regard to the management of hyperkalemia. Real-world studies are needed for a better understanding of the prevalence of hyperkalemia outside the clinical trial setting. There is a need to improve effective management of hyperkalemia, including classification …
Disruption Of Apol1-Mir193a Axis Induces Disorganization Of Podocyte Actin Cytoskeleton, V. Kumar, N. Paliwal, K. Ayasolla, H. Vashistha, A. Jha, N. Chandel, S. Chowdhary, M. A. Saleem, A. Malhotra, P. C. Singhal, +2 Additional Authors
Disruption Of Apol1-Mir193a Axis Induces Disorganization Of Podocyte Actin Cytoskeleton, V. Kumar, N. Paliwal, K. Ayasolla, H. Vashistha, A. Jha, N. Chandel, S. Chowdhary, M. A. Saleem, A. Malhotra, P. C. Singhal, +2 Additional Authors
Journal Articles
No abstract provided.
A 30-Year-Old Carrier Of Gaucher Disease With Multiple Myeloma., J. Chadha, T. Sahai, J. Schwimmer, D. Shani
A 30-Year-Old Carrier Of Gaucher Disease With Multiple Myeloma., J. Chadha, T. Sahai, J. Schwimmer, D. Shani
Journal Articles
We are reporting a case of a 30-year-old male with no past medical history who presented with new onset of renal failure, anemia, and splenomegaly and was diagnosed with multiple myeloma. Given the splenomegaly and the patient's Jewish heritage, blood tests were done and the patient was found to be a Gaucher disease carrier. The association of Gaucher disease and multiple myeloma has previously been reported; however, we want to describe the case of a young Gaucher disease carrier who developed multiple myeloma and provide a review of the literature.
Fibrillary Glomerulonephritis: An Update, J. L. Rosenstock, G. S. Markowitz
Fibrillary Glomerulonephritis: An Update, J. L. Rosenstock, G. S. Markowitz
Journal Articles
© 2019 International Society of Nephrology Fibrillary glomerulonephritis (FGN) is a rare proliferative form of glomerular disease characterized by randomly oriented fibrillar deposits with a mean diameter of 20 nm. By immunofluorescence (IF), the deposits stain for IgG, C3, and κ and λ light chains, suggesting that the fibrils may be composed of antigen-antibody immune complexes. A recent major advance in our understanding of the pathogenesis of FGN resulted from the discovery that a major component of the fibrils is DNA-J heat-shock protein family member B9 (DNAJB9), and immunohistochemical staining for DNAJB9 now makes it possible to diagnose FGN in …
Randomized Controlled Trial Of Subcutaneous Epoetin Alfa-Epbx Versus Epoetin Alfa In End-Stage Kidney Disease, S. Fishbane, B. S. Spinowitz, W. A. Wisemandle, N. E. Martin
Randomized Controlled Trial Of Subcutaneous Epoetin Alfa-Epbx Versus Epoetin Alfa In End-Stage Kidney Disease, S. Fishbane, B. S. Spinowitz, W. A. Wisemandle, N. E. Martin
Journal Articles
© 2019 Introduction: This double-blind, randomized controlled trial compared the safety and efficacy of subcutaneous epoetin alfa-epbx, an epoetin alfa biosimilar, with the reference product, epoetin alfa, in hemodialysis patients with end-stage kidney disease (ESKD) and anemia who were receiving epoetin alfa maintenance treatment. Methods: Eligible patients (n = 320) were randomized (1:1) to subcutaneous epoetin alfa-epbx or epoetin alfa in a titration phase; patients who demonstrated stable subcutaneous dosing (n = 246) were re-randomized to receive subcutaneous epoetin alfa-epbx or epoetin alfa 1 to 3 times per week in a 16-week maintenance phase. Co-primary endpoints were least-squares mean difference …
Potentially Avoidable Readmissions In United States Hemodialysis Patients, A. T. Mathew, L. Rosen, R. Pekmezaris, A. Kozikowski, D. W. Ross, T. Mcginn, K. Kalantar-Zadeh, S. Fishbane
Potentially Avoidable Readmissions In United States Hemodialysis Patients, A. T. Mathew, L. Rosen, R. Pekmezaris, A. Kozikowski, D. W. Ross, T. Mcginn, K. Kalantar-Zadeh, S. Fishbane
Journal Articles
© 2017 International Society of Nephrology Introduction: Patients with end-stage kidney disease have a high risk of 30-day readmission to hospital. These readmissions are financially costly to health care systems and are associated with poor health-related quality of life. The objective of this study was to describe and analyze the frequency, causes, and predictors of 30-day potentially avoidable readmission to hospital in patients on hemodialysis. Methods: We conducted a retrospective cohort study using the US Renal Data System data from January 1, 2008, to December 31, 2008. A total of 107,940 prevalent United States hemodialysis patients with 248,680 index hospital …